Famurewa Ademola Clement, Ejezie Fidelis Ebele
Department of Medical Biochemistry, Faculty of Basic Medical Sciences, Federal University, Ndufu-Alike, Ikwo, Ebonyi State, Nigeria.
Department of Medical Biochemistry, College of Medicine, University of Nigeria, Enugu Campus, Enugu State, Nigeria.
Avicenna J Phytomed. 2018 Jan-Feb;8(1):73-84.
Literature has confirmed the pathogenic role of cadmium (Cd) and its exposure in the induction of dyslipidemia implicated in the development and increasing incidence of cardiovascular diseases. The current study explored whether polyphenolics isolated from virgin coconut oil (VCO) prevent Cd-induced dyslipidemia and investigate the underlying mechanism of action, in rats.
Rats were pretreated with VCO polyphenols (10, 20 and 50 mg/kg body weight; orally) 2 weeks prior to concurrent Cd administration (5 mg/kg) for 5 weeks. Subsequently, serum concentrations of lipid and lipoprotein cholesterol and cardiovascular risk ratios were determined. Hepatic activities of superoxide dismutase (SOD) and catalase (CAT) as well as reduced glutathione (GSH) and malondialdehyde (MDA) contents were analyzed.
Sub-chronic Cd administration significantly increased the serum levels of total cholesterol, triglycerides, low density lipoprotein cholesterol and very low density lipoprotein cholesterol while markedly reduced high density lipoprotein cholesterol. Hepatic activities of SOD and CAT as well as GSH content were suppressed by Cd, whereas MDA level was obviously increased. The co-administration of VCO polyphenol with Cd remarkably restored lipid profile and cardiovascular risk ratios and stabilized antioxidant defense systems comparable to control group.
This is the first study presenting that polyphenols isolated from VCO prevent Cd-induced lipid abnormalities and cardiovascular risk ratios by improving antioxidant defense systems.
文献已证实镉(Cd)及其暴露在诱发血脂异常中起致病作用,而血脂异常与心血管疾病的发生和发病率增加有关。本研究探讨从初榨椰子油(VCO)中分离出的多酚类物质是否能预防镉诱导的血脂异常,并研究其在大鼠体内的潜在作用机制。
在同时给予镉(5mg/kg)5周前2周,给大鼠口服VCO多酚(10、20和50mg/kg体重)进行预处理。随后,测定血清脂质、脂蛋白胆固醇浓度和心血管风险比。分析肝脏中超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的活性以及还原型谷胱甘肽(GSH)和丙二醛(MDA)的含量。
亚慢性镉给药显著增加了血清总胆固醇、甘油三酯、低密度脂蛋白胆固醇和极低密度脂蛋白胆固醇水平,同时显著降低了高密度脂蛋白胆固醇水平。镉抑制了肝脏中SOD和CAT的活性以及GSH的含量,而MDA水平明显升高。VCO多酚与镉共同给药显著恢复了血脂水平和心血管风险比,并使抗氧化防御系统稳定,与对照组相当。
这是第一项表明从VCO中分离出的多酚通过改善抗氧化防御系统预防镉诱导的脂质异常和心血管风险比的研究。